SCOPUS 정보 검색 플랫폼

Volumn 63, Issue 26, 1998, Pages PL381-PL384

Hydroxypropyl-β-cyclodextrin and its combination with hydroxypropyl- methylcellulose increases aqueous solubility of Δ9-tetrahydrocannabinol

c NONE

Author keywords

Cyclodextrin; Hydroxypropylmethylcellulose; 9 tetrahydrocannabinol

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; CANNABIS; DRONABINOL; HYDROXYPROPYLMETHYLCELLULOSE;

ARTICLE; COMPLEX FORMATION; DRUG EFFECT; DRUG RESEARCH; DRUG SOLUBILITY;

CANNABIS; CANNABIS SATIVA;

EID: 18144436768 PISSN: 00243205 EISSN: None Source Type: Journal
DOI: 10.1016/s0024-3205(98)00528-1 Document Type: Article

Times cited : (38)

References (16)

1
- 0010319024
- McFarland Publishers, Jefferson, NC
- 1. M.L. MATHRE (ed.), Cannabis in medical practise, McFarland Publishers, Jefferson, NC, (1997).
- (1997) Cannabis in Medical Practise
- Mathre, M.L.¹

2
- 0003753476
- British Medical Association, Harwood Academic Publishers, Amsterdam
- 2. D.R. MORGAN (ed.), Therapeutic uses of Cannabis, British Medical Association, Harwood Academic Publishers, Amsterdam (1997).
- (1997) Therapeutic Uses of Cannabis
- Morgan, D.R.¹

3
- 0016138682
- 3. E.R. GARRETT and C.A. HUNT, J. Pharm. Sci. 63 1056-1064 (1974).
- (1974) J. Pharm. Sci. , vol.63 , pp. 1056-1064
- Garrett, E.R.¹ Hunt, C.A.²

4
- 0029797827
- 4. R. BRENNEISEN, A. EGLI, M.A. ELSOHLY, V. HENN and Y. SPIESS, Int. J. Clin. Pharm. Ther. 34 446-452 (1996).
- (1996) Int. J. Clin. Pharm. Ther. , vol.34 , pp. 446-452
- Brenneisen, R.¹ Egli, A.² Elsohly, M.A.³ Henn, V.⁴ Spiess, Y.⁵

5
- 8244248457
- 5. V.J. STELLA and R. RAJEWSKI, Pharm. Res. 14 556-567 (1997).
- (1997) Pharm. Res. , vol.14 , pp. 556-567
- Stella, V.J.¹ Rajewski, R.²

6
- 0021071267
- 6. Y. SHOYAMA, S. MORIMOTO and I. NISHIOKA, J. Nat. Prod. 46 633-637 (1983).
- (1983) J. Nat. Prod. , vol.46 , pp. 633-637
- Shoyama, Y.¹ Morimoto, S.² Nishioka, I.³

7
- 0017124784
- 7. D.W. FRANK, J.E. GREY and R.N. WEAVER, Am. J. Pathol. 83 367-382 (1976).
- (1976) Am. J. Pathol. , vol.83 , pp. 367-382
- Frank, D.W.¹ Grey, J.E.² Weaver, R.N.³

8
- 0023676038
- 8. A. YOSHIDA, H. ARIMA, K. UEKAMA and J. PITHA, Int. J. Pharm. 46 217-222 (1988).
- (1988) Int. J. Pharm. , vol.46 , pp. 217-222
- Yoshida, A.¹ Arima, H.² Uekama, K.³ Pitha, J.⁴

9
- 0031054513
- 9. T. IRIE and K. UEKAMA, J. Pharm. Sci. 86 147-162 (1997).
- (1997) J. Pharm. Sci. , vol.86 , pp. 147-162
- Irie, T.¹ Uekama, K.²

10
- 0000817098
- 10. T. HIGUCHI AND K.A. CONNORS, Adv. Anal. Chem. Instr. 4 117-212 (1965)
- (1965) Adv. Anal. Chem. Instr. , vol.4 , pp. 117-212
- Higuchi, T.¹ Connors, K.A.²

11
- 0028875098
- 11. P. JARHO, A. URTTI and T. JÄRVINEN, Pharm. Res. 12 1371-1375 (1995).
- (1995) Pharm. Res. , vol.12 , pp. 1371-1375
- Jarho, P.¹ Urtti, A.² Järvinen, T.³

12
- 0025259927
- 12. H.W. FRIJLINK, A.C. EISSENS, A.J.M. SCHOONEN and C.F. LERK, Int. J. Pharm. 64 195-205 (1990).
- (1990) Int. J. Pharm. , vol.64 , pp. 195-205
- Frijlink, H.W.¹ Eissens, A.C.² Schoonen, A.J.M.³ Lerk, C.F.⁴

13
- 0029852699
- 13. R. RAJEWSKI and V.J. STELLA, J. Pharm. Sci. 85 1142-1169 (1996).
- (1996) J. Pharm. Sci. , vol.85 , pp. 1142-1169
- Rajewski, R.¹ Stella, V.J.²

14
- 0030604721
- 14. P. JARHO, A. URTTI, D.W. PATE, P. SUHONEN and T. JÄRVINEN, Int. J. Pharm. 137 209-216 (1996).
- (1996) Int. J. Pharm. , vol.137 , pp. 209-216
- Jarho, P.¹ Urtti, A.² Pate, D.W.³ Suhonen, P.⁴ Järvinen, T.⁵

15
- 0028111609
- 15. T. LOFTSSON, H. FRIDRIKSDOTTIR, A.M. SIGURDARDOTTIR and H. UEDA, Int. J. Pharm. 110 169-177 (1994).
- (1994) Int. J. Pharm. , vol.110 , pp. 169-177
- Loftsson, T.¹ Fridriksdottir, H.² Sigurdardottir, A.M.³ Ueda, H.⁴

16
- 0343907824
- 16. T. and E. LOFTSSON STEFANSSON, Drug Dev. Int. Pharm. 23 473-481 (1997).
- (1997) Drug Dev. Int. Pharm. , vol.23 , pp. 473-481
- T¹ Loftsson Stefansson, E.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.